-
Pharmacogenomics,
often abbreviated "PGx," is the
study of the role of the
genome in drug response. Its name (pharmaco- + genomics)
reflects its combining...
-
Cancer pharmacogenomics is the
study of how
variances in the
genome influences an individual’s
response to
different cancer drug treatments. It is a subset...
- The
Pharmacogenomics Knowledgebase (PharmGKB) is a
publicly available,
online knowledge base
responsible for the aggregation, curation,
integration and...
-
provide the
greatest benefit, for
using a
particular drug or drugs.
Pharmacogenomics, on the
other hand, is the
broader application of
genomic technologies...
- The
Genetic Discrimination Observatory (GDO) is a Montreal-based
international network of
researchers and
other stakeholders who
support the
research and...
- Amiloride, sold
under the
trade name
Midamor among others, is a
medication typically used with
other medications to
treat high
blood pressure or swelling...
- attack, or
stroke in
patients already taking a statin. In 2015, a
pharmacogenomic sub-study of the dal-OUTCOMES
clinical trial on 5,749
individuals identified...
- VKORC1, but do
shorten the time to INR > 4.
Despite the
promise of
pharmacogenomic testing in
warfarin dosing, its use in
clinical practice is controversial...
-
cancer patients, as well as for
cardiology patients, radiology, and
pharmacogenomic testing for
patients with depression.
Tempus has a
global presence...
- for normal, reduced, and non-existent CYP2D6
function in subjects.
Pharmacogenomic tests are now
available to
identify patients with
variations in the...
